Starling Amaal J, Buse Dawn C, Cady Roger, Lenaburg Kevin, Kymes Steven
Division of Concussion, Division of Headache, Department of Neurology, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA.
Albert Einstein College of Medicine, Bronx, NY, USA.
J Racial Ethn Health Disparities. 2025 Aug 6. doi: 10.1007/s40615-025-02577-5.
Migraine studies consistently have low enrollment of non-White and/or Hispanic participants. This exploratory analysis assesses burden, treatment interventions, and care in people with high-frequency migraine and medication overuse (HFM + MO) in three racial/ethnic groups in the United States that responded to the Migraine Report Card online survey. The Migraine Report Card survey was fielded to adults (≥ 18 years). Eligible respondents reported current or previous HFM + MO (≥ 8 days/month with headache and ≥ 10 days/month of acute headache medication use over the last few months) and screened positive for migraine using the ID Migraine™ screener. Survey questions pertained to living with migraine, healthcare-patient communication, and treatment use and access. Subgroups large enough for analysis included non-Hispanic White, non-Hispanic Black, and Hispanic respondents currently experiencing HFM + MO. Acute medication optimization was assessed with the 4-item Migraine Treatment Optimization Questionnaire. Raw data were weighted to the US adult population. A total of 414 respondents currently experiencing HFM + MO were included in this analysis (White, n = 293; Black, n = 46; Hispanic, n = 75). In this population, despite similarities in migraine and insurance status, 54% of Black respondents reported being "very concerned" about their current health compared to 29% of White and 24% of Hispanic respondents. Twenty percent of White respondents reported using a preventive prescription migraine medication compared to 7% of Black and 10% of Hispanic respondents. Despite similar clinical and socioeconomic characteristics, healthcare disparities were observed, most notably among Black and Hispanic respondents experiencing HFM + MO. Further research regarding inequities in migraine care and disease impact is needed.
偏头痛研究一直存在非白人和/或西班牙裔参与者招募人数不足的问题。这项探索性分析评估了美国三个种族/族裔群体中患有高频偏头痛和药物过度使用（HFM + MO）的人群的负担、治疗干预措施和护理情况，这些群体参与了偏头痛报告卡在线调查。偏头痛报告卡调查针对成年人（≥18岁）。符合条件的受访者报告了当前或以前的HFM + MO（过去几个月中每月头痛≥8天且每月急性头痛药物使用≥10天），并使用ID Migraine™筛查工具筛查偏头痛呈阳性。调查问题涉及偏头痛患者的生活、医疗保健与患者沟通以及治疗使用和可及性。有足够大的子群体可供分析，包括目前患有HFM + MO的非西班牙裔白人、非西班牙裔黑人以及西班牙裔受访者。使用4项偏头痛治疗优化问卷评估急性药物优化情况。原始数据按美国成年人口进行加权。本分析共纳入了414名目前患有HFM + MO的受访者（白人，n = 293；黑人，n = 46；西班牙裔，n = 75）。在这个群体中，尽管偏头痛和保险状况相似，但54%的黑人受访者表示“非常担心”自己目前的健康状况，相比之下，白人受访者为29%，西班牙裔受访者为24%。20%的白人受访者报告使用预防性偏头痛处方药，相比之下，黑人受访者为7%，西班牙裔受访者为10%。尽管临床和社会经济特征相似，但仍观察到医疗保健方面的差异，最明显的是在患有HFM + MO的黑人和西班牙裔受访者中。需要进一步研究偏头痛护理和疾病影响方面的不平等问题。
